DS
Debashish Saha
About Debashish Saha
Data last updated:
Debashish Saha is a Director at Nucleus Laboratories (India) Limted (since 2023). The company operates in Pharma. Nucleus Laboratories (India) Limted reported revenue of ₹2.48 Cr (FY 2020).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Nucleus Laboratories (India) Limted U24231UP1999PLC024944 | Director | 01 Jun 2023 | 1999 | ₹2.48 Cr (FY 2020) | Active |
Board colleagues of Debashish Saha
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ashish Kumar Singh | 01189756 | Nucleus Laboratories (India) Limted | Director |
| Chandana Shrivastava | 09523772 | Nucleus Laboratories (India) Limted | Director |
| Gyan Prakash Shrivastava | 08545629 | Nucleus Laboratories (India) Limted | Director |
| Himani Shukla | 11219612 | Nucleus Laboratories (India) Limted | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Debashish Saha
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Debashish Saha
Debashish Saha currently holds 1 directorship: Nucleus Laboratories (India) Limted (Director, since 01 Jun 2023, revenue ₹2.48 Cr (FY 2020)).
Debashish Saha was first appointed on 01 Jun 2023 as Director at Nucleus Laboratories (India) Limted.
The current boards of Debashish Saha's companies include Ashish Kumar Singh (Nucleus Laboratories (India) Limted), Chandana Shrivastava (Nucleus Laboratories (India) Limted), Gyan Prakash Shrivastava (Nucleus Laboratories (India) Limted), Himani Shukla (Nucleus Laboratories (India) Limted).